Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Taxes (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Change in Taxes for 15 consecutive years, with $335000.0 as the latest value for Q4 2025.

  • Quarterly Change in Taxes rose 245.36% to $335000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$134000.0 through Dec 2025, down 120.15% year-over-year, with the annual reading at -$134000.0 for FY2025, 120.15% down from the prior year.
  • Change in Taxes for Q4 2025 was $335000.0 at Anika Therapeutics, up from -$21000.0 in the prior quarter.
  • The five-year high for Change in Taxes was $1.3 million in Q2 2022, with the low at -$1.2 million in Q1 2021.
  • Average Change in Taxes over 5 years is $59350.0, with a median of -$17000.0 recorded in 2025.
  • The sharpest move saw Change in Taxes plummeted 848.19% in 2021, then surged 800.0% in 2024.
  • Over 5 years, Change in Taxes stood at -$888000.0 in 2021, then soared by 214.19% to $1.0 million in 2022, then plummeted by 58.38% to $422000.0 in 2023, then plummeted by 77.01% to $97000.0 in 2024, then soared by 245.36% to $335000.0 in 2025.
  • According to Business Quant data, Change in Taxes over the past three periods came in at $335000.0, -$21000.0, and -$435000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.